Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuo Tani

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular and Clinical Oncology|April 29, 2017
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)Masayoshi Miyawaki, Katsuhiko Naoki, Satoshi Yoda, et al.
Frontiers in Immunology|October 5, 2020
Tumor-Derived cGAMP Regulates Activation of the VasculatureMarco Campisi, Shriram K Sundararaman, Sarah E Shelton, et al.
Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Annals of Clinical and Translational Neurology|July 4, 2024
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese populationLisa Shigematsu, Ryusei Kimura, Hideki Terai, et al.
Respiratory Investigation|September 29, 2024
Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort studyEmiko Matsuyama, Jun Miyata, Hideki Terai, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Cancer Research|June 4, 2021
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung CancerKota Ishioka, Hiroyuki Yasuda, Junko Hamamoto, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Cancer Immunology Research|June 9, 2022
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H Knelson, Elena V Ivanova, Mubin Tarannum, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular and Clinical Oncology|April 29, 2017
Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)Masayoshi Miyawaki, Katsuhiko Naoki, Satoshi Yoda, et al.
Frontiers in Immunology|October 5, 2020
Tumor-Derived cGAMP Regulates Activation of the VasculatureMarco Campisi, Shriram K Sundararaman, Sarah E Shelton, et al.
Cancer Research|September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung CancerRyohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Annals of Clinical and Translational Neurology|July 4, 2024
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese populationLisa Shigematsu, Ryusei Kimura, Hideki Terai, et al.
Respiratory Investigation|September 29, 2024
Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort studyEmiko Matsuyama, Jun Miyata, Hideki Terai, et al.
Cancer Discovery|January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor ImmunityTetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Cancer Research|June 4, 2021
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung CancerKota Ishioka, Hiroyuki Yasuda, Junko Hamamoto, et al.
The Journal of Clinical Investigation|November 5, 2020
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockadeKartik Sehgal, Andrew Portell, Elena V Ivanova, et al.
Cancer Immunology Research|June 9, 2022
Activation of Tumor-Cell STING Primes NK-Cell TherapyErik H Knelson, Elena V Ivanova, Mubin Tarannum, et al.
Pageof 5